Expanding Product Portfolio Grupo Cimed offers over 700 products across health, beauty, and hygiene segments, with a growing presence in the pharmaceutical manufacturing sector. This extensive and diverse product range presents numerous opportunities to cross-sell or expand into new health-related categories within existing retail channels.

Robust Manufacturing Capacity With an annual production of 240 million units and servicing over 30,000 points of sale monthly through its 22 distribution centers, Cimed demonstrates solid supply chain capabilities and high-volume distribution potential that can meet large client demands in the healthcare and retail sectors.

Market Position and Growth As a major Brazilian player with 5,001 to 10,000 employees and 100% local investment, Cimed competes effectively with multinational companies, providing sales opportunities for local distributors, healthcare providers, and pharmacies seeking reliable and competitive pharmaceutical partners in Brazil.

Technology and Digital Presence Utilizing platforms like Facebook Pixel, Google Analytics, and WordPress indicates a strong digital strategy, which could facilitate targeted marketing and outreach efforts, making it easier for sales teams to connect with key decision-makers and healthcare professionals via online channels.

Financial Stability and Investment With recent funding of 55 million dollars, a revenue range of 250 to 500 million dollars, and a cash runway into mid-2026, Cimed is financially stable and positioned for growth, opening opportunities for partnership, bulk purchasing, and expanding distribution channels in the pharmaceutical and retail markets.